Impact of etiology of hepatocellular carcinoma on treatment outcomes in a real-world database.

被引：0
|
作者：
Brown, Timothy J.
Mamtani, Ronac
Gimotty, Phyllis A.
Karasic, Thomas Benjamin
Yang, Yu-Xiao
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
[2] Univ Penn, Sch Med, Philadelphia, PA USA
[3] Univ Penn, Penn Med, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
508
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [1] Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysis
    Morgan, Christopher Ll
    Inzucchi, Silvio E.
    Puelles, Jorge
    Jenkins-Jones, Sara
    Currie, Craig J.
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2140 - 2147
  • [2] Development and validation of a real-world clinicogenomic database.
    Singal, Gaurav
    Miller, Peter Grant
    Agarwala, Vineeta
    He, Jie
    Gossai, Anala
    Frank, Shannon
    Bourque, David
    Bowser, Bryan
    Caron, Thomas
    Baydur, Ezra
    Seidl-Rathkopf, Kathi
    Ivanov, Ivan
    Parker, Alex
    Guria, Ameet
    Frampton, Garrett Michael
    Jaskiw, Ann
    Feuchtbaum, Dana
    Nussbaum, Nathan Coleman
    Abernethy, Amy Pickar
    Miller, Vincent A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: A real-world, multicenter study
    Rossari, F.
    Tada, T.
    Shimose, S.
    Kudo, M.
    Yoo, C.
    Cheon, J.
    Finkelmeier, F.
    Lim, H. Y.
    Presa, J.
    Masi, G.
    Bergamo, F.
    Amadeo, E.
    Vitiello, F.
    Foti, S.
    Persano, M.
    Piscaglia, F.
    Scartozzi, M.
    Cascinu, S.
    Rimini, M.
    Gardini, A. Casadei
    ANNALS OF ONCOLOGY, 2023, 34 : S1547 - S1547
  • [4] Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study
    Rossari, Federico
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Yoo, Changhoon
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Presa, Jose
    Masi, Gianluca
    Bergamo, Francesca
    Amadeo, Elisabeth
    Vitiello, Francesco
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Iavarone, Massimo
    Cabibbo, Giuseppe
    Montes, Margarida
    Foschi, Francesco Giuseppe
    Vivaldi, Caterina
    Solda, Caterina
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Hiraoka, Atsushi
    LIVER CANCER, 2024, 13 (05) : 522 - 536
  • [5] Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
    Timothy J. Brown
    Ronac Mamtani
    Phyllis A. Gimotty
    Thomas B. Karasic
    Yu-Xiao Yang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2345 - 2354
  • [6] Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
    Brown, Timothy J.
    Mamtani, Ronac
    Gimotty, Phyllis A.
    Karasic, Thomas B.
    Yang, Yu-Xiao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2345 - 2354
  • [7] Atezolizumab plus bevacizumab versus lenvatinib as first-line systemic therapy for treatment of hepatocellular carcinoma in a real-world population: Outcomes from the HCC CHORD database.
    Freeman, Mark
    Krishnan, Tharani
    Lee, Cha Len
    Dibajnia, Pooya
    Ramjeesingh, Ravi
    Vasconcelos, Joao Paulo Solar
    Lyubetska, Hanna
    Ding, Philip Q.
    Lim, Howard J.
    Knox, Jennifer J.
    Meyers, Brandon M.
    Gordon, Vallerie Lynn
    Cheung, Winson Y.
    Tam, Vincent C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Real-world treatment patterns and sequencing for metastatic renal cell carcinoma (mRCC): Results from the Flatiron database.
    George, Saby
    Faccone, Jillian
    Huo, Stephen
    Zhang Ying
    Stwalley, Brian
    Hamilton, Melissa
    Le, Trong Kim
    Ejzykowicz, Flavia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [9] Real-world evidence in hepatocellular carcinoma
    Mospan, Andrea R.
    Morris, Heather L.
    Fried, Michael W.
    LIVER INTERNATIONAL, 2021, 41 : 61 - 67
  • [10] A real-world study of camrelizumab in the treatment of hepatocellular carcinoma.
    Zeng, Yong-Yi
    Guo, Wu-hua
    Zhang, Zhibo
    Shi, Xi
    Su, Yongjie
    Cai, Qinghe
    Peng, Jianyang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345